Genetic Technologies Net Income 2010-2021 | GENE
Genetic Technologies net income from 2010 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Genetic Technologies Annual Net Income
(Millions of US $) |
| 2021 |
$-5 |
| 2020 |
$-4 |
| 2019 |
$-5 |
| 2018 |
$-4 |
| 2017 |
$-6 |
| 2016 |
$-6 |
| 2015 |
$-7 |
| 2014 |
$-9 |
| 2013 |
$-10 |
| 2012 |
$-5 |
| 2011 |
$1 |
| 2010 |
$-8 |
| 2009 |
$-6 |
Genetic Technologies Quarterly Net Income
(Millions of US $) |
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-12-31 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| 2015-12-31 |
|
| 2015-06-30 |
|
| 2014-12-31 |
|
| 2014-06-30 |
|
| 2013-12-31 |
|
| 2013-06-30 |
|
| 2012-12-31 |
|
| 2012-06-30 |
|
| 2011-12-31 |
|
| 2011-06-30 |
|
| 2010-12-31 |
|
| 2010-06-30 |
|
| 2009-12-31 |
|
| 2009-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.019B |
$0.000B |
|
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
|
